Phase II study of pegylated liposomal doxorubicin (Caelyx) in advanced hepatocellular carcinoma (HHC). Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Ruff, P
  • Moodley, SD
  • Rapoport, BL
  • Chasen, Martin
  • Jacobs, C
  • Hacking, D
  • Voroblof, DA

publication date

  • January 1, 2000